Heru, Inc. products

Don’t let age-related macular degeneration (AMD) be your practice’s blind spot. Heru`s Market-Leading AMD Portfolio. Heru’s AMD portfolio leverages contrast sensitivity & dark adaptation, which studies have shown may aid physicians in the detection of AMD-related changes up to three years before drusen are visible allowing for earlier intervention and management of the disease.